FDA Investigator Lisa M Schultz
Lisa M Schultz has conducted inspections on 30 sites in 1 countries as of 10 Nov 2021. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
30
Last Inspection Date:
10 Nov 2021
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Lisa M Schultz:
Adrian Ddela Rosa,
Adrian H Garcia,
Adriana Meza,
Amanda L Fyles,
Brenda C Hamilton,
Carey A Watson,
Christopher M Jenner,
Corey A Dunn,
Deborah W Hsu,
Donzel R Lee,
Efrain E Meneses,
Elizabeth Q Maccorkell,
Emmanuel B Diric,
Fidel Carrillo,
Francisco X Cano,
Garrad R Poole,
Gerardo I Martinez,
Janice L Straight,
John R Myung,
Jose O Caraballo Rivera,
Luis E Gonzalez,
Luis R Soto,
Marco A Solorio,
Mark A Guerra,
Nicholas Fragedakis,
Nicholas L Hunt,
Odun A Balogun,
Ounchith J Phabmixay,
Patricia P Wrona,
Peter D Cavazos,
Rafael Salinas,
Rhonda Anderson,
Samuel S Cuevas,
Takiyah S Gilmore Embery,
Timothy T Kapsala,
Travell D Sawyer,
Truong Xuan Nguyen (Andy),
Walden H Lee,
Xavier M Rios
Lisa M Schultz's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2013 | FDA 483 | CBSCHEM Limited - Form 483, 2013-06-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more